世界の再構成剤用バイアルアダプター市場は、予測期間中に約7.57 %のCAGRで推移し、2022年から2026年の間に4億6,098万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。この市場は、慢性疾患の増加、老年層の拡大、バイアルアダプターを使用する利点に関する認知度の向上が要因となっています。さらに、慢性疾患の増加は市場の成長を後押しすることも予想されます。
本調査では、バイアルアダプターの製造に使用される原材料の価格が変動していることが、今後数年間の再構成剤用バイアルアダプター市場の成長を促す主要因の1つであると特定しています。また、凍結乾燥薬剤の需要の高まりと技術の採用の増加が、市場の大きな需要につながると考えています。
Technavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な再構成剤用バイアルアダプター市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Therapeutic Area
5.1 Market segments
Exhibit 24: Chart on Therapeutic Area - Market share 2021-2026 (%)
Exhibit 25: Data Table on Therapeutic Area - Market share 2021-2026 (%)
5.2 Comparison by Therapeutic Area
Exhibit 26: Chart on Comparison by Therapeutic Area
Exhibit 27: Data Table on Comparison by Therapeutic Area
5.3 Infectious diseases - Market size and forecast 2021-2026
Exhibit 28: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
5.4 Autoimmune diseases - Market size and forecast 2021-2026
Exhibit 32: Chart on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
5.5 Metabolic conditions - Market size and forecast 2021-2026
Exhibit 36: Chart on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Metabolic conditions - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Metabolic conditions - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Therapeutic Area
Exhibit 44: Market opportunity by Therapeutic Area ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Agilent Technologies Inc.
Exhibit 93: Agilent Technologies Inc. - Overview
Exhibit 94: Agilent Technologies Inc. - Business segments
Exhibit 95: Agilent Technologies Inc. - Key news
Exhibit 96: Agilent Technologies Inc. - Key offerings
Exhibit 97: Agilent Technologies Inc. - Segment focus
10.4 B. Braun Melsungen AG
Exhibit 98: B. Braun Melsungen AG - Overview
Exhibit 99: B. Braun Melsungen AG - Business segments
Exhibit 100: B. Braun Melsungen AG - Key news
Exhibit 101: B. Braun Melsungen AG - Key offerings
Exhibit 102: B. Braun Melsungen AG - Segment focus
10.5 Becton Dickinson and Co.
Exhibit 103: Becton Dickinson and Co. - Overview
Exhibit 104: Becton Dickinson and Co. - Business segments
Exhibit 105: Becton Dickinson and Co. - Key news
Exhibit 106: Becton Dickinson and Co. - Key offerings
Exhibit 107: Becton Dickinson and Co. - Segment focus
10.6 Dedecke GmbH
Exhibit 108: Dedecke GmbH - Overview
Exhibit 109: Dedecke GmbH - Product / Service
Exhibit 110: Dedecke GmbH - Key offerings
10.7 Merck KGaA
Exhibit 111: Merck KGaA - Overview
Exhibit 112: Merck KGaA - Product / Service
Exhibit 113: Merck KGaA - Key offerings
10.8 Miltenyi Biotec B.V. and Co. KG
Exhibit 114: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibit 115: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibit 116: Miltenyi Biotec B.V. and Co. KG - Key news
Exhibit 117: Miltenyi Biotec B.V. and Co. KG - Key offerings
10.9 Shimadzu Corp.
Exhibit 118: Shimadzu Corp. - Overview
Exhibit 119: Shimadzu Corp. - Business segments
Exhibit 120: Shimadzu Corp. - Key news
Exhibit 121: Shimadzu Corp. - Key offerings
Exhibit 122: Shimadzu Corp. - Segment focus
10.10 Stevanato Group S.p.A
Exhibit 123: Stevanato Group S.p.A - Overview
Exhibit 124: Stevanato Group S.p.A - Product / Service
Exhibit 125: Stevanato Group S.p.A - Key offerings
10.11 Thermo Fisher Scientific Inc.
Exhibit 126: Thermo Fisher Scientific Inc. - Overview
Exhibit 127: Thermo Fisher Scientific Inc. - Business segments
Exhibit 128: Thermo Fisher Scientific Inc. - Key news
Exhibit 129: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 130: Thermo Fisher Scientific Inc. - Segment focus
10.12 West Pharmaceutical Services Inc.
Exhibit 131: West Pharmaceutical Services Inc. - Overview
Exhibit 132: West Pharmaceutical Services Inc. - Business segments
Exhibit 133: West Pharmaceutical Services Inc. - Key news
Exhibit 134: West Pharmaceutical Services Inc. - Key offerings
Exhibit 135: West Pharmaceutical Services Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 136: Inclusions checklist
Exhibit 137: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 138: Currency conversion rates for US$
11.4 Research methodology
Exhibit 139: Research methodology
Exhibit 140: Validation techniques employed for market sizing
Exhibit 141: Information sources
11.5 List of abbreviations
Exhibit 142: List of abbreviations
Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Therapeutic Area - Market share 2021-2026 (%)
Exhibits25: Data Table on Therapeutic Area - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Therapeutic Area
Exhibits27: Data Table on Comparison by Therapeutic Area
Exhibits28: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Metabolic conditions - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Metabolic conditions - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Therapeutic Area ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Agilent Technologies Inc. - Overview
Exhibits94: Agilent Technologies Inc. - Business segments
Exhibits95: Agilent Technologies Inc. - Key news
Exhibits96: Agilent Technologies Inc. - Key offerings
Exhibits97: Agilent Technologies Inc. - Segment focus
Exhibits98: B. Braun Melsungen AG - Overview
Exhibits99: B. Braun Melsungen AG - Business segments
Exhibits100: B. Braun Melsungen AG - Key news
Exhibits101: B. Braun Melsungen AG - Key offerings
Exhibits102: B. Braun Melsungen AG - Segment focus
Exhibits103: Becton Dickinson and Co. - Overview
Exhibits104: Becton Dickinson and Co. - Business segments
Exhibits105: Becton Dickinson and Co. - Key news
Exhibits106: Becton Dickinson and Co. - Key offerings
Exhibits107: Becton Dickinson and Co. - Segment focus
Exhibits108: Dedecke GmbH - Overview
Exhibits109: Dedecke GmbH - Product / Service
Exhibits110: Dedecke GmbH - Key offerings
Exhibits111: Merck KGaA - Overview
Exhibits112: Merck KGaA - Product / Service
Exhibits113: Merck KGaA - Key offerings
Exhibits114: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibits115: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibits116: Miltenyi Biotec B.V. and Co. KG - Key news
Exhibits117: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibits118: Shimadzu Corp. - Overview
Exhibits119: Shimadzu Corp. - Business segments
Exhibits120: Shimadzu Corp. - Key news
Exhibits121: Shimadzu Corp. - Key offerings
Exhibits122: Shimadzu Corp. - Segment focus
Exhibits123: Stevanato Group S.p.A - Overview
Exhibits124: Stevanato Group S.p.A - Product / Service
Exhibits125: Stevanato Group S.p.A - Key offerings
Exhibits126: Thermo Fisher Scientific Inc. - Overview
Exhibits127: Thermo Fisher Scientific Inc. - Business segments
Exhibits128: Thermo Fisher Scientific Inc. - Key news
Exhibits129: Thermo Fisher Scientific Inc. - Key offerings
Exhibits130: Thermo Fisher Scientific Inc. - Segment focus
Exhibits131: West Pharmaceutical Services Inc. - Overview
Exhibits132: West Pharmaceutical Services Inc. - Business segments
Exhibits133: West Pharmaceutical Services Inc. - Key news
Exhibits134: West Pharmaceutical Services Inc. - Key offerings
Exhibits135: West Pharmaceutical Services Inc. - Segment focus
Exhibits136: Inclusions checklist
Exhibits137: Exclusions checklist
Exhibits138: Currency conversion rates for US$
Exhibits139: Research methodology
Exhibits140: Validation techniques employed for market sizing
Exhibits141: Information sources
Exhibits142: List of abbreviations
